As soon as a harmful agent is eradicated, NF-κB signaling needs to be downregulated to maintain tissue homeostasis required to prevent inflammation, autoimmune disease, and oncogenesis [49,51]. This evidence concerns the gene NFKB1 and autoimmune disease.